NM_207122.2(EXT2):c.93del (p.Ile32fs) AND not provided

Germline classification:: Likely pathogenic (1 submission)
Last evaluated:: May 6, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003145020.3

Allele description [Variation Report for NM_207122.2(EXT2):c.93del (p.Ile32fs)]

NM_207122.2(EXT2):c.93del (p.Ile32fs)

Gene:

EXT2:exostosin glycosyltransferase 2 [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

11p11.2

Genomic location:

Preferred name:

NM_207122.2(EXT2):c.93del (p.Ile32fs)

HGVS:

NC_000011.10:g.44107805del
NG_007560.1:g.17257del
NM_000401.3:c.192del
NM_001178083.3:c.93del
NM_001389628.1:c.93del
NM_001389630.1:c.93del
NM_207122.2:c.93delMANE SELECT
NP_000392.3:p.Ile65fs
NP_001171554.1:p.Ile32fs
NP_001376557.1:p.Ile32fs
NP_001376559.1:p.Ile32fs
NP_997005.1:p.Ile32Leufs
NP_997005.1:p.Ile32fs
LRG_494t1:c.192del
LRG_494t2:c.93del
LRG_494:g.17257del
LRG_494p1:p.Ile65fs
NC_000011.9:g.44129355del
NM_207122.1:c.93del
NM_207122.1:c.93delC

Protein change:

I32fs

Molecular consequence:

NM_000401.3:c.192del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001178083.3:c.93del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001389628.1:c.93del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001389630.1:c.93del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_207122.2:c.93del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003832363	Revvity Omics, Revvity	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely pathogenic (May 6, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003832363

Revvity Omics, Revvity

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely pathogenic
(May 6, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Revvity Omics, Revvity, SCV003832363.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Mar 16, 2024

ClinVar

Relating variation to medicine